RT Book, Section
A1 Cadiz, Christine L.
A1 Ha, David R.
A2 Lam, Jerika T.
A2 Gutierrez, Mary A.
A2 Shah, Samit
SR Print(0)
ID 1179510448
T1 Transplant Pharmacogenomics
T2 Pharmacogenomics: A Primer for Clinicians
YR 2021
FD 2021
PB McGraw Hill
PP New York, NY
SN 9781260457100
LK accesspharmacy.mhmedical.com/content.aspx?aid=1179510448
RD 2024/04/19
AB LEARNING  OBJECTIVESDiscuss  the  clinical  considerations  of  pharmacogenomics  in  solid  organ  and  hematopoietic  stem  cell  transplantation.Describe  general  mechanisms  of  action,  pharmacokinetics/pharmacodynamics,  adverse  drug  reactions,  and  drug  interactions  of  transplant  immunosuppressant  agents.Identify  gene  targets  that  influence  pharmacokinetic  or  pharmacodynamic  phenotypes  of  transplant  immunosuppressant  agents.Given  a  case  with  pharmacogenetic  testing  results,  provide  recommendations  regarding  selection,  dosing,  monitoring,  and  other  considerations  for  transplant  immunosuppressant  agents.